Projects

RNDr. Ivana Fridrichová, CSc.
senior scientist

National

Current
  • Impact of the gut microbiome on the treatment and prognosis of patients with testicular germ cell tumors.
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • The emerging role of the microbiome in hematologic cancer patients receiving high-dose chemotherapy with hematopoietic stem cell transplantation.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Identification of biomarkers of resistance to cisplatin-based chemotherapy in urogenital cancer
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Regulation of epithelial-mesenchymal transition by microRNA and promoter methylation in invasive breast cancer
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Turning cisplatin-resistant testiular germ cell tumors into a curable disease
    Program: SRDA
    Duration: 1. 8. 2018 – 31. 12. 2021
  • Expression analysis of miRNA genes regulating the biology of cancer stem cells in breast cancer patients
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Micro-RNA expression profiles for discrimination of endometrioid and serous types of endometrial cancer
    Program: Other projects
    Duration: 1. 12. 2018 – 31. 12. 2020
  • DNA methylation profiles in genes associated with breast cancer metasasising
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Histone modification and DNA methylation relationship in transcription silencing of cancer associated genes
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Implementation of methods for analysis of epigenetic changes in genes involved in epithelial-mesenchymal transition in breast cancer
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
  • Identification of predictive epigenetic biomarkers in breast cancers
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 8. 2014
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 10. 2013
  • Diagnoses of Socially Important Diseases in Slovakia Based on Modern Biotechnologies.
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 10. 2013
  • Epigenetic inactivation of selected genes for growth, invazivity and metastasis regulation in breast cancers
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • DNA methylation in hereditary and sporadic colorectal carcinomas with mismatch repair defect
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Epithelial-mesenchymal transition in the model of breast carcinoma stem cells in vitro
    Program: SRDA
    Duration: 1. 3. 2006 – 1. 3. 2009
  • -
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees